ALK and neuroblastoma: Combaret et al., used ddPCR to evaluate the mutational status of ALK hotspots (F1174L exon 23:3520 and 3522, R1275Q exon 25:3824) using cfDNA in a cohort of 114 neuroblastoma patients.